BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38244615)

  • 1. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features.
    Tondi Resta I; Gubbiotti MA; Montone KT; Livolsi VA; Baloch ZW
    Hum Pathol; 2024 Feb; 144():53-60. PubMed ID: 38244615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
    Thompson LDR
    Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.
    Jeong SI; Kim W; Yu HW; Choi JY; Ahn CH; Moon JH; Choi SI; Cha W; Jeong WJ; Park SY; Na HY
    Endocr Pathol; 2023 Sep; 34(3):287-297. PubMed ID: 37515661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.
    Poma AM; Macerola E; Ghossein RA; Tallini G; Basolo F
    Thyroid; 2024 Mar; 34(3):314-323. PubMed ID: 38115626
    [No Abstract]   [Full Text] [Related]  

  • 6. A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.
    Ng DL; van Zante A; Griffin A; Hills NK; Ljung BM
    Thyroid; 2021 Jul; 31(7):1086-1095. PubMed ID: 33371796
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
    Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
    Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into noninvasive follicular thyroid neoplasms with papillary-like nuclear features: does the initial proposal on noninvasive follicular thyroid neoplasms with papillary-like nuclear features behavior hold true?
    Tondi Resta I; Gubbiotti MA; Montone KT; Livolsi VA; Baloch ZW
    Hum Pathol; 2023 Nov; 141():139-148. PubMed ID: 37633533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degenerative atypia in benign thyroid nodules: a potential diagnostic pitfall on fine-needle aspiration.
    Lam H; Saoud C; Shi Q; Wong KS; Cibas ES; Rooper LM; Baloch Z; Ali SZ
    J Am Soc Cytopathol; 2023; 12(5):341-350. PubMed ID: 37230891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
    Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of "suspicious for malignancy" for non-papillary carcinoma diagnoses on thyroid fine-needle aspiration.
    Chowsilpa S; Jones R; Hang JF; Ali SZ
    J Am Soc Cytopathol; 2021; 10(2):148-154. PubMed ID: 32773337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
    Goldstein RE; Netterville JL; Burkey B; Johnson JE
    Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.